```mermaid
flowchart TD
classDef gene fill:#0a1f0a,stroke:#4caf50
classDef protein fill:#0a1929,stroke:#2196f3
classDef disease fill:#2d0f0f,stroke:#e91e63
classDef pathway fill:#3e2200,stroke:#ff9800
classDef mechanism fill:#1a0a1f,stroke:#9c27b0
classDef therapeutic fill:#e0f2f1,stroke:#009688
TRAF3["TRAF3"] -->|"implicated_in"| neurodegeneration["neurodegeneration"]
TRAF3["TRAF3"] -.->|"inhibits"| TLR4["TLR4"]
TRAF3["TRAF3"] -.->|"inhibits"| CAT["CAT"]
TRAF3["TRAF3"] -.->|"inhibits"| Inflammation["Inflammation"]
TRAF3["TRAF3"] ==>|"activates"| Diabetes["Diabetes"]
TRAF3["TRAF3"] -->|"associated_with"| Tumor["Tumor"]
TRAF3["TRAF3"] -.->|"inhibits"| Ms["Ms"]
TRAF3["TRAF3"] -->|"regulates"| Toll_Like_Receptor["Toll-Like Receptor"]
TRAF3["TRAF3"] -.->|"inhibits"| Oxidative_Stress["Oxidative Stress"]
TRAF3["TRAF3"] -.->|"inhibits"| Nf__b["Nf-Kb"]
TRAF3["TRAF3"] -.->|"inhibits"| TLR["TLR"]
TRAF3["TRAF3"] -.->|"inhibits"| UBIQUITIN["UBIQUITIN"]
TRAF3["TRAF3"] -->|"regulates"| TRAF6["TRAF6"]
TRAF3["TRAF3"] -->|"regulates"| NDP52["NDP52"]
TRAF3["TRAF3"] -->|"regulates"| AUTOPHAGY["AUTOPHAGY"]
TRAF3["TRAF3"] -.->|"inhibits"| LC3["LC3"]
TRAF3["TRAF3"] -->|"regulates"| Autophagy["Autophagy"]
TRAF3["TRAF3"] -.->|"inhibits"| Toll_Like_Receptor["Toll-Like Receptor"]
TRAF3["TRAF3"] ==>|"activates"| INFLAMMATION["INFLAMMATION"]
TRAF3["TRAF3"] -->|"regulates"| UBIQUITIN["UBIQUITIN"]
TRAF3["TRAF3"] ==>|"activates"| Als["Als"]
TRAF3["TRAF3"] ==>|"activates"| L
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRAF3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TRAF3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>TNF Receptor-Associated Factor 3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7188</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000126777</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y4K0</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein Coding</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CAP-1, CAP1, RNF83</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">40 edges</a></td>
</tr>
</table>
TRAF3 (TNF Receptor-Associated Factor 3) is a crucial signaling adapter protein that regulates multiple innate immune signaling pathways, including [NF-kappaB](/mechanisms/nfkb-signaling-pathway), MAPK, and type I interferon responses. It plays dual roles in both promoting and inhibiting inflammation depending on cellular context and stimulus type, making it a key regulator of neuroinflammation in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) [@chen2023].
TRAF3 is a member of the TNF receptor-associated factor (TRAF) family of adapter proteins that mediate signaling from the TNF receptor superfamily and Toll-like receptor (TLR) family. The protein contains several functional domains:
TRAF3 regulates multiple critical signaling pathways:
NF-κB Signaling: TRAF3 negatively regulates non-canonical NF-κB signaling by targeting NIK (NF-κB-inducing kinase) for K48-linked ubiquitination and proteasomal degradation. This prevents constitutive activation of the non-canonical NF-κB pathway, which is crucial for controlling inflammatory gene expression in the brain. Loss of TRAF3 leads to NIK accumulation and aberrant NF-κB activation, resulting in heightened inflammatory responses [@liu2023].
Type I Interferon Response: TRAF3 is essential for RIG-I-like receptor (RLR)-mediated type I interferon production upon viral infection. It interacts with MAVS (Mitochondrial Antiviral-Signaling protein) to activate IRF3/IRF7-mediated transcription of interferon genes. This antiviral response has implications for understanding viral contributions to neurodegeneration [@gao2023].
TLR Signaling: TRAF3 modulates TLR-induced inflammatory responses by interacting with MyD88 and TRIF adaptor proteins. It regulates the balance between pro-inflammatory and anti-inflammatory responses following TLR activation, with context-dependent effects that vary by cell type and stimulus [@lee2019].
NLRP3 Inflammasome Regulation: TRAF3 directly interacts with NLRP3 and ASC to suppress inflammasome activation in microglia. This function is particularly relevant in neurodegenerative contexts where inflammasome activation contributes to pathology [@lin2016].
TRAF3 is expressed throughout the central nervous system with cell-type-specific patterns:
TRAF3 plays multifaceted roles in Alzheimer's disease pathogenesis:
Amyloid-β Interaction: TRAF3 modulates the inflammatory response to amyloid-β ([Aβ](/proteins/amyloid-beta)) plaques. Loss of TRAF3 function correlates with increased neuroinflammation around plaques. Studies show TRAF3 expression is significantly decreased in AD hippocampus and prefrontal cortex [@wang2020].
Tau Pathology: TRAF3 deficiency exacerbates tau pathology-induced neuroinflammation and accelerates cognitive decline in model systems. Restoring TRAF3 expression reduces inflammatory markers and improves neuronal function [@chen2023].
Therapeutic Targeting: Recent studies explore TRAF3-modulating compounds for AD treatment. Strategies include:
TRAF3 polymorphisms have been associated with PD susceptibility in multiple populations, with particularly significant findings in East Asian cohorts [@zhao2024]:
α-Synucleinopathy: TRAF3-mediated signaling influences α-synuclein aggregation and dopaminergic neuron viability. Microglial TRAF3 deficiency leads to enhanced neuroinflammation in PD models, accelerating dopaminergic neuron loss [@miao2024].
Substantia Nigra: Reduced TRAF3 expression in the substantia nigra pars compacta correlates with disease severity. This may contribute to microglial dysregulation and chronic neuroinflammation characteristic of PD.
LRRK2 Interaction: Studies suggest TRAF3 interacts with [LRRK2](/genes/lrrk2) signaling pathways, potentially linking genetic and inflammatory factors in PD pathogenesis.
TRAF3 is significantly downregulated in ALS motor cortex and spinal cord:
Motor Neuron Pathology: TRAF3 deficiency exacerbates motor neuron degeneration in ALS models. Loss of TRAF3 in microglia leads to hyperactivated inflammatory responses that harm surviving motor neurons [@xu2022].
Astrocyte Dysfunction: Altered TRAF3 expression in astrocytes contributes to non-cell-autonomous toxicity in ALS. Astrocytic TRAF3 deficiency promotes secretion of inflammatory mediators that harm motor neurons.
Therapeutic Potential: Restoring TRAF3 expression in glia represents a potential therapeutic approach for ALS [@wang2021].
TRAF3 variants increase susceptibility to herpes simplex encephalitis, demonstrating its critical role in CNS antiviral immunity. This has implications for understanding the proposed link between herpesvirus infection and neurodegeneration [@huo2021].
TRAF3 interacts with numerous signaling pathways relevant to neurodegeneration:
TRAF3 Signaling in Neurodegeneration
graph LR
TNF["TNF Family Ligands"] --> TRAF3
TLR["TLR Ligands"] --> TRAF3
RLR["RLR Viral RNA"] --> TRAF3
TRAF3 --> NIK["NIK"]
TRAF3 --> MAVS["MAVS"]
TRAF3 --> MyD88["MyD88"]
NIK --> NFKB["Non-canonical NF-kappaB"]
MAVS --> IRF["IRF3/IRF7"]
MyD88 --> TLRNFKB["TLR-induced NF-kappaB"]
NFKB --> INFLAM["Inflammatory Genes"]
IRF --> IFN["Type I IFN"]
TLRNFKB --> INFLAM2["Inflammatory Genes"]
INFLAM --> NEURO["Neurodegeneration"]
TRAF3 expression levels in cerebrospinal fluid (CSF) or peripheral blood mononuclear cells may serve as biomarkers for:
Several TRAF3-targeted approaches are in development:
The following diagram shows the key molecular relationships involving TRAF3 discovered through SciDEX knowledge graph analysis: